Qube Research & Technologies Ltd - SESEN BIO INC ownership

SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 2 filers reported holding SESEN BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SESEN BIO INC
ValueSharesWeighting
Q4 2022$8,334
-86.3%
13,674
-90.5%
0.00%
Q3 2022$61,000
-55.8%
144,425
-15.0%
0.00%
-100.0%
Q2 2022$138,000
-66.0%
169,834
+8.8%
0.00%
-83.3%
Q1 2021$406,000
-9.0%
156,027
-52.8%
0.01%0.0%
Q4 2020$446,000
-49.6%
330,303
-47.7%
0.01%
-53.8%
Q3 2020$885,000
+1375.0%
632,101
+652.9%
0.01%
+1200.0%
Q2 2020$60,000
-77.0%
83,955
-66.6%
0.00%
-87.5%
Q4 2019$261,000251,2430.01%
Other shareholders
SESEN BIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
Eversept Partners, LP 1,300,000$728,7800.18%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,749,219$981,0000.18%
Alyeska Investment Group, L.P. 1,400,000$785,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 417,000$234,0000.01%
Tortoise Investment Management, LLC 10,000$6,0000.00%
HRT FINANCIAL LP 20,647$11,0000.00%
TWO SIGMA INVESTMENTS, LP 26,641$15,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 736,829$413,0000.00%
REILLY FINANCIAL ADVISORS, LLC 500$00.00%
BlackRock Inc. 2,143,229$1,202,0000.00%
View complete list of SESEN BIO INC shareholders